Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2009-10-30
2011-11-08
Zeman, Mary (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S020000, C703S011000, C703S012000, C707S700000, C435S006100, C435S007100, C536S024100
Reexamination Certificate
active
08055452
ABSTRACT:
A method provides an index that is indicative of the state of a subject, as to a biological condition, based on a sample from the subject. An embodiment of this method includes: deriving from the sample a profile data set, the profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables evaluation of the biological condition; and in deriving the profile data set, achieving such measure for each constituent under measurement conditions that are substantially repeatable; and applying values from the profile data set to an index function that provides a mapping from an instance of a profile data set into a single-valued measure of biological condition, so as to produce an index pertinent to the biological condition of the subject.
REFERENCES:
patent: 5506145 (1996-04-01), Bull et al.
patent: 5643765 (1997-07-01), Wiley
patent: 5696130 (1997-12-01), Jones et al.
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5811231 (1998-09-01), Farr et al.
patent: 5846720 (1998-12-01), Foulkes et al.
patent: 5866330 (1999-02-01), Kinzier et al.
patent: 5882925 (1999-03-01), Falb et al.
patent: 5955269 (1999-09-01), Ghai et al.
patent: 5968784 (1999-10-01), Spinella et al.
patent: 5994076 (1999-11-01), Chenchik et al.
patent: 6022683 (2000-02-01), Poirier
patent: 6132969 (2000-10-01), Stoughton et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6150169 (2000-11-01), Smith et al.
patent: 6165709 (2000-12-01), Friend et al.
patent: 6185561 (2001-02-01), Balaban et al.
patent: 6203987 (2001-03-01), Friend et al.
patent: 6203988 (2001-03-01), Kambara et al.
patent: 6218122 (2001-04-01), Friend et al.
patent: 6222093 (2001-04-01), Marton et al.
patent: 6232065 (2001-05-01), Robinson et al.
patent: 6245517 (2001-06-01), Chen et al.
patent: 6309823 (2001-10-01), Cronin et al.
patent: 2001/0018182 (2001-08-01), Friend et al.
patent: 2001/0029018 (2001-10-01), Danenberg et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0012932 (2002-01-01), Wang
patent: 2002/0045197 (2002-04-01), Friend et al.
patent: 9-503921 (1997-04-01), None
patent: 10-261029 (1998-09-01), None
patent: WO 94/23023 (1994-10-01), None
patent: WO 97/41261 (1997-06-01), None
patent: WO 98/24935 (1998-06-01), None
patent: WO-98/31838 (1998-07-01), None
patent: WO 99/04251 (1999-01-01), None
patent: WO 99/44063 (1999-02-01), None
patent: WO-99/23254 (1999-05-01), None
patent: WO 99/46403 (1999-09-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/54510 (1999-10-01), None
patent: WO 99/11822 (1999-11-01), None
patent: WO 99/57130 (1999-11-01), None
patent: WO 99/58720 (1999-11-01), None
patent: WO 00/11208 (2000-02-01), None
patent: WO 00/22172 (2000-04-01), None
patent: WO 00/28092 (2000-05-01), None
patent: WO 00/58728 (2000-05-01), None
patent: WO 00/71756 (2000-11-01), None
patent: WO 01/11082 (2001-02-01), None
patent: WO 01/12851 (2001-02-01), None
patent: WO 01/20998 (2001-03-01), None
patent: WO 01/23614 (2001-04-01), None
patent: WO 01/25473 (2001-04-01), None
patent: WO 01/27321 (2001-04-01), None
patent: WO 01/29261 (2001-04-01), None
patent: WO 01/29269 (2001-04-01), None
patent: WO 01/30972 (2001-05-01), None
patent: WO 01/32928 (2001-05-01), None
patent: WO 03/040404 (2003-05-01), None
Patent Owner's Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 1 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 2 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 3 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 4 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 5 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 6 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 7 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Exhibit 8 filed with Response to Office Action mailed May 20, 2008 for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Third Party Comments in Reply to Patent Owner's Response to Office Action for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Second Declaration of Dr. Joffre Baker filed with Third Party Comments in Reply to Patent Owner's Response to Office Action for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Declaration of Victor V. Tryon filed as Exhibit A of Third Party Comments in Reply to Patent Owner's Response to Office Action for Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Office Communication mailed Oct. 7, 2009 in Re-Examination of U.S. Patent No. 6,964,850 (Re-Examination Control No. 95/001,032).
Hoffmann et al., “Disease Fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type-1 and type-2 cytokine-mediated inflammatory reactions”, FASEB J., 15(13):2545-2547 (published online Sep. 17, 2001).
Respondent Brief—Third Party Requester, dated Jun. 28, 2010.
Rebuttal Brief in anInter PartesReexamination Proceeding (37 CFR 41.68), dated Oct. 4, 2010.
Asthana, D., et al., Differential Effects of 1FN-γ on Kidney Cell Expression of MHC Class II Molecules, Kidney Cell Associated Molecules and Their Stimulatory Capacity in Mixed Lymphocyte Kidney Cell Culture; Transpl Immunol, vol. 1, pp. 282-293; 1993.
Beasley, Ellen M., et al. “Statistical Refinement of Primer Design Parameters,” Academic Press, PCR Applications, 1999, pp. 59-71.
Beer, David G., et al., “Gene-Expression Profiles Predict Survival of Patients With Lung Adenocarcinoma,” Nature Medicine, Aug. 2002, vol. 8, No. 8, pp. 816-824.
Buchwald, D., et al., Markers of Inflammation and Immune Activation in Chronic Fatigue and Chronic Fatigue Syndrome; J Rheumatol, vol. 24, pp. 372-376; 1997.
Cheronis, J.C., et al., “Utility of High Precision QPCR in the Assessment of Anti-Inflammatory Drug Action,” Clinical Chemistry, vol. 28, No. 6, Supplement, Jun. 2002, p. A172.
Coenen, et al., A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle, Growth Hormone & IGF Research 1999, 9, 179-186 Article No. ghir.1999.0104.
Cole, et al., “The Genetics of Cancer—A 3D Model,” Nature Genetics Supplement, vol. 21, Jan. 1999.
Eisenberg, et al., “Protein Function in the Post-Genomic Era,” Nature, vol. 405:823-826, Jun. 15, 2000.
Guan-Chiun Lee, et al., Analysis of the Gene Family Encoding Lipases in candid rugosa by Competitive Reverse Transcription-PCR, Applied and Environmental Microbiology, Sep. 1999, pp. 3888-3895.
Humbert, M., et al., Relationship Between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma; Am J Respir Crit Care Med, vol. 156, pp. 704-708, 1997 (Information Disclosure Statement—p. 6 of 12).
Imai, S., et al., High Levels of Expression of Collagenase-3 (MM P-13) in Pathological Conditions Associated with a Foreign-Body Reaction; J Bone Joint Surg, vol. 80-B, pp. 701-710, Jul. 1998.
Jensen, et al., “Competitive reverse transcription polymerase chain reaction for quantifying pre-MRNA and mRNA of major acute phase proteins”, Journal of Immunological Methods, 215 (1998), pp. 4
Bankaitis-Davis Danute M.
Bevilacqua Michael P.
Cheronis John C.
Tryon Victor
Life Technologies Corporation
Zeman Mary
LandOfFree
Identification, monitoring and treatment of disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification, monitoring and treatment of disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification, monitoring and treatment of disease and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282877